Abstract
Background: Quinacrine is an older antimalarial drug that remains in use for a variety of illnesses including treatment-resistant giardiasis.
Case Presentation: We report a patient with no prior psychiatric history who developed mild, prodromal psychiatric symptoms when treated with quinacrine for treatment-resistant giardiasis. Symptoms resolved when the drug was stopped, recurred with greater severity (requiring involuntary psychiatric hospitalization) when restarted and promptly resolved again when the drug was finally stopped.
Conclusion: Although quinacrine remains in use today, providers may be unaware of its potential for serious neuropsychiatric toxicity.
Keywords: Quinacrine, quinolines, psychosis, adverse drug reaction, case report, giardiasis.
Current Drug Safety
Title:A Case of Quinacrine-induced Psychosis: Case Report
Volume: 16 Issue: 3
Author(s): Anangamanjari Pedapudi*, Jonathan Stewart and Ankita Patel
Affiliation:
- Department of Psychiatry and Behavioral Neurosciences, University of South Florida Morsani College of Medicine, Tampa, FL33612,United States
Keywords: Quinacrine, quinolines, psychosis, adverse drug reaction, case report, giardiasis.
Abstract:
Background: Quinacrine is an older antimalarial drug that remains in use for a variety of illnesses including treatment-resistant giardiasis.
Case Presentation: We report a patient with no prior psychiatric history who developed mild, prodromal psychiatric symptoms when treated with quinacrine for treatment-resistant giardiasis. Symptoms resolved when the drug was stopped, recurred with greater severity (requiring involuntary psychiatric hospitalization) when restarted and promptly resolved again when the drug was finally stopped.
Conclusion: Although quinacrine remains in use today, providers may be unaware of its potential for serious neuropsychiatric toxicity.
Export Options
About this article
Cite this article as:
Pedapudi Anangamanjari *, Stewart Jonathan and Patel Ankita , A Case of Quinacrine-induced Psychosis: Case Report, Current Drug Safety 2021; 16 (3) . https://dx.doi.org/10.2174/1574886315666201005103142
DOI https://dx.doi.org/10.2174/1574886315666201005103142 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects
Current Cancer Drug Targets Thyroid Function and Obesity: From Mechanisms to the Benefits of Levothyroxine in Obese Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment
Mini-Reviews in Medicinal Chemistry Opportunities for Photoacoustic-Guided Drug Delivery
Current Drug Targets Detection of Early Cancer: Genetics or Immunology? Serum Autoantibody Profiles as Markers of Malignancy
Anti-Cancer Agents in Medicinal Chemistry Novel Therapeutic Strategies Against Cancer: Marine-derived Drugs May Be the Answer?
Anti-Cancer Agents in Medicinal Chemistry Taste and Hypertension in Humans: Targeting Cardiovascular Disease
Current Pharmaceutical Design Recent Advances in Chemical Genomics
Current Medicinal Chemistry Organic Anion Transporting Polypeptides (OATPs): Regulation of Expression and Function
Current Drug Metabolism Meet Our Editorial Board Member
Endocrine, Metabolic & Immune Disorders - Drug Targets New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan as Drivers of Oncogenesis and Potential Drug Targets
Current Cancer Drug Targets Glucagon-Like Peptide-1-Mediated Modulation of Inflammatory Pathways in the Diabetic Brain: Relevance to Alzheimer’s Disease
Current Alzheimer Research Lung Cancer May Increase Serum Procalcitonin Level
Infectious Disorders - Drug Targets Quantitative Proteomics with Isotope Dilution Analysis: Principles and Applications
Current Proteomics Molecular Elements of Apoptosis-Regulating Pathways in Follicular Thyroid Cells: Mining for Novel Therapeutic Targets in the Treatment of Thyroid Carcinoma
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Current Cancer Therapy Reviews Effects of Aging on Thyroidal Function and Proliferation
Current Aging Science Misfolded Proteins and Human Diseases
Protein & Peptide Letters Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets